ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Megadeals aside, pharma M&A actually dropped in the first half of 2019
August 01, 2019When Bristol-Myers Squibb kicked off 2019 by making a $74 billion bid for Celgene, biopharma watchers everywhere declared it to be the end of the mergers-and-acquisitions drought in the sector. -
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
January 23, 2019After two recent, huge tie-ups between Takeda and Shire and Bristol-Myers Squibb and Celgene, megamergers seem to be a biopharma trend. But Roche isn't interested in it, its chairman said.
Pharma Sources Insight January 2025
